Content
Ecopipam Ecopipam is a dopamine antagonist and it is in its last clinical trial. So if it works, it’ll be pushed for FDA approval. Dr Maguire who is a stutterer himself and his team are behind this drug. This is from an article in August 28 2019. When do you think it’ll be finally released to the public? Assuming you would have to take it every morning, would it be expensive? What are your hopes in term of finding a cure or even an effective treatment?
Themes
Anticipation & AvoidanceMeds & SubstancesCauses & Variability
Subthemes
Overthinking & MonitoringHelpful Med OutcomesNeurological & Brain